Cross-sectional Study of Serum IL-6 in Schizophrenia


Study Description: The purpose of this study is to examine the relationship between inflammation in the blood, immune cells, aspects of metabolism, and relapse (worsening of symptoms) in patients with schizophrenia and related disorders. Illness relapses are common in schizophrenia and are associated with adverse outcomes, such as hospitalization. To better understand and predict relapse in schizophrenia is an important opportunity that could be used to assess treatment effectiveness, potentially identify new ways to prevent relapse, and potentially identify new treatments for this disorder.

Contact for Enrollment

    
     (706) 721-4445
    brmiller@gru.edu

    Submit Information Online

Principal Investigator: Brian Miller

Eligibility Criteria: Inclusion criteria: 1) age 18-70, 2) Diagnosis of schizophrenia, schizoaffective disorder, other psychotic disorder OR no history of mental illness (for control group) 3) No history of an immune disorder (such as HIV/AIDS, Rheumatoid Arthritis, Lupus)

Compensation: Yes, subjects will be compensated.

Compensation Explanation: Particpants will be paid $25 for completing the visit. Payments will be made by check approximately two weeks following completion of the study.

 

Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.